Insider · CIK 0001405637

REED VICKIE S

Reports to the SEC for 3 companies · SOLANA BEACH, CA

sec.gov

Transactions

Companies

Filings

CIK

0001405637

Forms 4 and 5

Insider transactions

24 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2025-12-17	EVOKEvoke Pharma Inc · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−1,250 sh	—	—	0
2025-12-17	EVOKEvoke Pharma Inc · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−5,833 sh	—	—	0
2025-12-17	EVOKEvoke Pharma Inc · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−1,250 sh	—	—	0
2025-05-21	EVOKEvoke Pharma Inc · Stock Option (Right to Buy)A Award	Director	AAward	+1,250 sh	—	—	8,333
2025-01-28	EVOKEvoke Pharma Inc · Stock Option (Right to Buy)A Award	Director	AAward	+5,833 sh	—	—	5,833
2024-05-22	EVOKEvoke Pharma Inc · Stock Option (Right to Buy)A Award	Director	AAward	+15K sh	—	—	15,000
2023-05-10	EVOKEvoke Pharma Inc · Stock Option (Right to Buy)A Award	Director	AAward	+15K sh	—	—	15,000
2022-05-24	DMK PHARMACEUTICALS CorpStock Appreciation RightA Award	Director	AAward	+50K sh	—	—	50,000
2022-04-27	EVOKEvoke Pharma Inc · Stock Option (Right to Buy)A Award	Director	AAward	+58K sh	—	—	58,000
2022-01-18	Mirati Therapeutics, Inc.S Sale	SVP, Chief Accounting Officer	SSale	−533 sh	$120.48	−$64.2K	15,369
2022-01-14	Mirati Therapeutics, Inc.A Award	SVP, Chief Accounting Officer	AAward	+5,377 sh	—	—	15,902
2022-01-14	Mirati Therapeutics, Inc.Employee Stock Option (Right to Buy)A Award	SVP, Chief Accounting Officer	AAward	+8,910 sh	—	—	8,910
2022-01-07	Mirati Therapeutics, Inc.S Sale	SVP, Chief Accounting Officer	SSale	−345 sh	$135.94	−$46.9K	10,525
2022-01-04	Mirati Therapeutics, Inc.S Sale	SVP, Chief Accounting Officer	SSale	−758 sh	$147.74	−$112K	10,870
2021-05-13	EVOKEvoke Pharma Inc · Stock Option (Right to Buy)A Award	Director	AAward	+70K sh	—	—	70,000
2021-01-15	Mirati Therapeutics, Inc.A Award	SVP, Chief Accounting Officer	AAward	+4,157 sh	—	—	11,628
2021-01-15	Mirati Therapeutics, Inc.Employee Stock Option (Right to Buy)A Award	SVP, Chief Accounting Officer	AAward	+6,499 sh	—	—	6,499
2021-01-07	Mirati Therapeutics, Inc.S Sale	SVP, Chief Accounting Officer	SSale	−241 sh	$216.33	−$52.1K	7,471
2021-01-06	Mirati Therapeutics, Inc.S Sale	SVP, Chief Accounting Officer	SSale	−11 sh	$215.70	−$2,372.74	8,239
2021-01-06	Mirati Therapeutics, Inc.S Sale	SVP, Chief Accounting Officer	SSale	−527 sh	$210.28	−$111K	7,712
2020-11-02	Mirati Therapeutics, Inc.Option Grant (Right to Buy)A Award	SVP, Chief Accounting Officer	AAward	+2,522 sh	—	—	2,522
2020-11-02	Mirati Therapeutics, Inc.Option Grant (Right to Buy)A Award	SVP, Chief Accounting Officer	AAward	+2,523 sh	—	—	2,523
2020-01-06	Mirati Therapeutics, Inc.A Award	SVP, Chief Accounting Officer	AAward	+2,750 sh	—	—	8,250
2020-01-06	Mirati Therapeutics, Inc.Employee Stock Option (Right to Buy)A Award	SVP, Chief Accounting Officer	AAward	+5,500 sh	—	—	5,500

Recent filings

Accepted (ET)
Dec 174
REED VICKIE S0001193125-25-322638
SEC(opens sec.gov)
May 224
REED VICKIE S0000950170-25-076438
SEC(opens sec.gov)
Jan 294
REED VICKIE S0000950170-25-010533
SEC(opens sec.gov)
May 244
REED VICKIE S0000950170-24-064692
SEC(opens sec.gov)
May 114
REED VICKIE S0001209191-23-028796
SEC(opens sec.gov)
May 264
REED VICKIE S0001387131-22-006484
SEC(opens sec.gov)
Apr 284
REED VICKIE S0001209191-22-026076
SEC(opens sec.gov)
Jan 184
REED VICKIE S0001214659-22-000858
SEC(opens sec.gov)
Jan 74
REED VICKIE S0001214659-22-000470
SEC(opens sec.gov)
Jan 64
REED VICKIE S0001214659-22-000417
SEC(opens sec.gov)
May 174
REED VICKIE S0001209191-21-033358
SEC(opens sec.gov)
Jan 204
REED VICKIE S0001214659-21-000685
SEC(opens sec.gov)
Jan 84
REED VICKIE S0001214659-21-000341
SEC(opens sec.gov)

Companies

Address

C/O EVOKE PHARMA, INC. 420 STEVENS AVENUE, SUITE 230

SOLANA BEACH, CA, 92075